English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduTo identify cancers earlier and better understand when they may be easier to treat, the National Cancer Institute (NCI), part of the National Institutes of Health, has launched a new clinical trials network to evaluate emerging technologies for cancer screening.
Tag: NCI
Rogel earns SPORE grant designed to further research on radiosensitization
An inter-departmental group of researchers at the University of Michigan Rogel Cancer Center received a grant from the National Cancer Institute to further research on radiosensitization, the process of making tumors more vulnerable to radiation treatment.
Researchers at Case Western Reserve, University Hospitals to assess effectiveness of novel MRI method for breast cancer patients
Researchers at Case Western Reserve University
(CWRU) and University Hospitals (UH) will study whether a new magnetic resonance imaging exam can predict how chemotherapy’s effectiveness for a woman with breast cancer based on a single round of treatment.
Cell competition may explain cancer relapses, UT Southwestern research suggests
A normal process called cell competition, in which healthy tissues eliminate unhealthy cells, could be responsible for cancer relapses in patients months or years after they were declared cancer-free
New Center for Experimental Therapeutics in Cancer advances promising treatments
UC Davis Comprehensive Cancer Center has launched a Center for Experimental Therapeutics in Cancer to accelerate promising cancer therapies from the lab to the bedside. The idea is to advance precision medicine that leads to more effective, less toxic cancer therapies.
AACI Congratulates Dr. Monica Bertagnolli on Appointment as NCI Director
AACI commends the Biden administration on its decision to appoint surgical oncologist Monica Bertagnolli, MD, as the next director of the National Cancer Institute (NCI). Dr. Bertagnolli is the first woman to serve as NCI director.
AACI Welcomes New Member, Koch Institute for Integrative Cancer Research at MIT
The Association of American Cancer Institutes (AACI) welcomes its newest member, the Koch Institute for Integrative Cancer Research at MIT.
Roswell Park and University of Chicago Medicine Comprehensive Cancer Centers Awarded Nearly $9M for Ovarian Cancer Research
For years, scientists at Roswell Park Comprehensive Cancer Center and the University of Chicago Medicine Comprehensive Cancer Center have devoted themselves to research to better understand ovarian cancer.
Moffitt Cancer Center Physician Receives NCI Cancer Clinical Investigator Team Leadership Award
Zeynep Eroglu, M.D., assistant member of the Cutaneous Oncology Department at Moffitt Cancer Center, received the 2021 Cancer Clinical Investigator Team Leadership Award from the National Cancer Institute.
NCI-designated cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track
The COVID-19 pandemic has interrupted delivery of key health services
for children and adolescents, including HPV vaccination for cancer prevention.
Renowned Roswell Park Immunologist Promoted to Endowed Chair Role
Following a national search, Roswell Park Comprehensive Cancer Center has promoted Pawel Kalinski, MD, PhD, to Jacobs Family Endowed Chair of Immunology, Chief of the Division of Translational Immuno-Oncology and Senior Vice President for Basic Science.
Nature Article Highlights UAMS Effort to Share COVID-19 Images on National Cancer Database
Data experts with the University of Arkansas for Medical Sciences (UAMS) have uploaded clinical images of COVID-19 patients to a publically available national database that scientists can use in researching the disease and its impact in a global pandemic.
Sara Federico, M.D., receives NCI award for her leadership in developing clinical trials for pediatric cancer
Sara Federico, MD, received the NCI award for substantial impact in the field of childhood solid tumors through the development and conduct of clinical trials
Four MSK Researchers Receive 2020 Outstanding Investigator Award from the National Cancer Institute
Four MSK researchers out of 15 winners nationwide were named recipients of the prestigious award. They will each receive a grant of up to $600,000 per year for seven years to support their research in cancer.
St. Jude immunologist Thirumala-Devi Kanneganti, Ph.D., receives NCI Outstanding Investigator Award
The National Cancer Institute award provides extended support for researchers to pursue projects with groundbreaking cancer research potential
Houston Methodist oncologist available to comment on NCI model predicting 10,000 additional breast/colorectal cancer deaths due to COVID-19
The National Cancer Institute predicts the number of people who will die from breast or colorectal cancer in the U.S. will increase by nearly 10,000 over the next decade because of COVID-19’s impact on oncology care. Charles Geyer, M.D., oncologist…
Roswell Park’s Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort
A team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center has earned a five-year, $14.54 million award from the National Cancer Institute (NCI) to expand a promising immunotherapy platform. Funded through the NCI’s Program Project Grant program, this prestigious five-year grant will fund five clinical trials, all focused on a strategy for making some of the most common immunotherapies work for more cancer patients.
New High-Throughput Method to Study Gene Splicing at an Unprecedented Scale Reveals New Details About the Process
Genes are like instructions, but with options for building more than one thing. Daniel Larson, senior investigator at the National Cancer Institute, studies this gene “splicing” process, which happens in normal cells and goes awry in blood cancers like leukemia.